Xiong Chen

Dr. Xiong Chen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
JCJiahao Cai
Jiahao Cai
XLXiaoyu Li
Xiaoyu Li
SWShangbin Wu
Shangbin Wu
YTYang Tian
Yang Tian
YZYani Zhang
Yani Zhang
WCWen-Xiong Chen
Wen-Xiong Chen
Background: Metabolic disturbance has been reported in patients with epilepsy. Still, the evidence about the causal role of metabolites in facilitating or preventing epilepsy is lacking. Systematically investigating the causality between blood metabolites and epilepsy would help provide novel targets for epilepsy screening and prevention. Methods: We conducted two-sample Mendelian randomization (MR) analysis. Data for 486 human blood metabolites came from a genome-wide association study (GWAS) comprising 7824 participants. GWAS data for epilepsy were obtained from the International League Against Epilepsy (ILAE) consortium for primary analysis and the FinnGen consortium for replication and meta-analysis. Sensitivity analyses were conducted to evaluate heterogeneity and pleiotropy. Results: 482 out of 486 metabolites were included for MR analysis following rigorous genetic variants selection. After IVW and sensitivity analysis filtration, six metabolites with causal effects on epilepsy were identified from the ILAE consortium. Only four metabolites remained significant associations with epilepsy when combined with the FinnGen consortium [uridine: odds ratio (OR) = 2.34, 95% confidence interval (CI) = 1.48–3.71, P = 0.0003; 2-hydroxystearate: OR = 1.61, 95% CI = 1.19–2.18, P = 0.002; decanoylcarnitine: OR = 0.82, 95% CI = 0.72–0.94, P = 0.004; myo-inositol: OR = 0.77, 95% CI = 0.62–0.96, P = 0.02]. Conclusion: The evidence that the four metabolites mentioned above are associated with epilepsy in a causal way provides a novel insight into the underlying mechanisms of epilepsy by integrating genomics with metabolism, and has an implication for epilepsy screening and prevention.

31 March 2023 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
MLMingli Luo
Mingli Luo
JCJiahao Cai
Jiahao Cai
SLShulu Luo
Shulu Luo
XHXiaosi Hong
Xiaosi Hong
LXLingxin Xu
Lingxin Xu
WFWen Fu
Wen Fu
Background: Previous studies have reported that gut microbiota is associated with an increased risk of chronic kidney disease (CKD) progression. However, whether gut microbiota has a causal effect on the development of CKD has not been revealed. Thus, we aimed to analyze the potential causal effect of gut microbiota on the risk of CKD using mendelian randomization (MR) study.Materials and Methods: Independent single nucleotide polymorphisms closely associated with 196 gut bacterial taxa (N = 18340) were identified as instrumental variables. Two-sample MR was performed to evaluate the causal effect of gut microbiota on CKD (N = 480698), including inverse-variance-weighted (IVW) method, weighted median method, MR-Egger, mode-based estimation and MR-PRESSO. The robustness of the estimation was tested by a series of sensitivity analyses including Cochran’s Q test, MR-Egger intercept analysis, leave-one-out analysis and funnel plot. Statistical powers were also calculated.Results: The genetically predicted higher abundance of order Desulfovibrionales was causally associated with an increased risk of CKD (odds ratio = 1.15, 95% confidence interval: 1.05-1.26; p = 0.0026). Besides, we also detected potential causalities between nine other taxa (Eubacterium eligens group, Desulfovibrionaceae, Ruminococcaceae UCG-002, Deltaproteobacteria, Lachnospiraceae UCG-010, Senegalimassilia, Peptostreptococcaceae, Alcaligenaceae and Ruminococcus torques group) and CKD (p < 0.05). No heterogeneity or pleiotropy was detected for significant estimates.Conclusion: We found that Desulfovibrionales and nine other taxa are associated with CKD, thus confirming that gut microbiota plays an important role in the pathogenesis of CKD. Our work also provides new potential indicators and targets for screening and prevention of CKD.

16 November 2022 in European Journal of Clinical Investigation
Verified
Journal Article
Open access
GHGuiwu Huang
Guiwu Huang
JCJiahao Cai
Jiahao Cai
WLWenchang Li
Wenchang Li
QLQiaowei Lu
Qiaowei Lu
XCXiong Chen
Xiong Chen
PWPeihui Wu
Peihui Wu
Background: The causal inference between leisure sedentary behaviour (LSB) and rheumatoid arthritis (RA) is still controversial because of potential residual confounding and reverse causality.Methods: The present study used publicly available large‐scale genome‐wide association studies (GWAS) of LSB (television watching, computer use, and driving) and RA to perform a two‐sample Mendelian randomization (MR) study to evaluate the causal effect of LSB on the risk of RA. We detected significant causal associations using the multiplicative random effects‐inverse variance weighted (MRE‐IVW) method, the maximum likelihood, robust adjusted profile scores, the weighted median, MR‐Egger regression, and several complementary sensitivity analyses. Risk factor analysis was also conducted to further investigate potential mediators linking causal inference.Results: Increased genetic liability to leisure television watching was significantly associated with a higher risk of RA (MRE‐IVW method; OR = 2.46, 95% CI 1.77–3.41; p = 8.35 × 10−8). MR estimates indicated that prolonged leisure computer use was causally associated with a lower risk of RA (MRE‐IVW method; OR = 0.23, 95% CI 0.12–0.46; p = 2.19 × 10−5). However, we found no evidence for a causal effect of leisure driving on the risk of RA (MRE‐IVW method; OR = 0.59, 95% CI 0.10–3.41; p = 0.557). No pleiotropy was detected by the sensitivity analysis.Conclusions: This study supports a causal association between prolonged leisure television watching and an increased risk of RA. Additionally, prolonged computer use might be a protective factor for RA.

20 September 2023 in Cancer Innovation
Verified
Journal Article
Open access
LLLin Lv
Lin Lv
ZZZhengtao Zhang
Zhengtao Zhang
DZDongbo Zhang
Dongbo Zhang
QCQinchang Chen
Qinchang Chen
YLYuanfang Liu
Yuanfang Liu
XCXiong Chen
Xiong Chen
Background: Neuroblastoma is one common pediatric malignancy notorious for high temporal and spatial heterogeneities. More than half of its patients develop distant metastases involving vascularized organs, especially the bone marrow. It is thus necessary to have an economical, noninvasive method without much radiation for follow‐ups. Radiomics has been used in many cancers to assist accurate diagnosis but not yet in bone marrow metastasis in neuroblastoma.Methods: A total of 182 patients with neuroblastoma were retrospectively collected and randomly divided into the training and validation sets. Five‐hundred and seventy‐two radiomics features were extracted from magnetic resonance imaging, among which 41 significant ones were selected via T‐test for model development. We attempted 13 machine‐learning algorithms and eventually chose three best‐performed models. The integrative performance evaluations are based on the area under the curves (AUCs), calibration curves, risk deciles plots, and other indexes.Results: Extreme gradient boosting, random forest (RF), and adaptive boosting were the top three to predict bone marrow metastases in neuroblastoma while RF was the most accurate one. Its AUC was 0.90 (0.86–0.93), F1 score was 0.82, sensitivity was 0.76, and negative predictive value was 0.79 in the training set. The values were 0.82 (0.71–0.93), 0.80, 0.75, and 0.92 in the validation set, respectively.Conclusions: Radiomics models are likely to contribute more to metastatic diagnoses and the formulation of personalized healthcare strategies in clinics. It has great potential of being a revolutionary method to replace traditional interventions in the future.

28 June 2024 in Cancer Innovation
Verified
Journal Article
Open access
XCXiong Chen
Xiong Chen
QCQinchang Chen
Qinchang Chen
YLYuanfang Liu
Yuanfang Liu
YQYa Qiu
Ya Qiu
LLLin Lv
Lin Lv
FSFangpeng Shu
Fangpeng Shu
Background: Bone marrow is the leading site for metastasis from neuroblastoma and affects the prognosis of patients with neuroblastoma. However, the accurate diagnosis of bone marrow metastasis is limited by the high spatial and temporal heterogeneity of neuroblastoma. Radiomics analysis has been applied in various cancers to build accurate diagnostic models but has not yet been applied to bone marrow metastasis of neuroblastoma.Methods: We retrospectively collected information from 187 patients pathologically diagnosed with neuroblastoma and divided them into training and validation sets in a ratio of 7:3. A total of 2632 radiomics features were retrieved from venous and arterial phases of contrast‐enhanced computed tomography (CT), and nine machine learning approaches were used to build radiomics models, including multilayer perceptron (MLP), extreme gradient boosting, and random forest. We also constructed radiomics‐clinical models that combined radiomics features with clinical predictors such as age, gender, ascites, and lymph gland metastasis. The performance of the models was evaluated with receiver operating characteristics (ROC) curves, calibration curves, and risk decile plots.Results: The MLP radiomics model yielded an area under the ROC curve (AUC) of 0.97 (95% confidence interval [CI]: 0.95–0.99) on the training set and 0.90 (95% CI: 0.82–0.95) on the validation set. The radiomics‐clinical model using an MLP yielded an AUC of 0.93 (95% CI: 0.89–0.96) on the training set and 0.91 (95% CI: 0.85–0.97) on the validation set.Conclusions: MLP‐based radiomics and radiomics‐clinical models can precisely predict bone marrow metastasis in patients with neuroblastoma.

7 December 2022 in Cancer Innovation
Verified
Journal Article
Open access
XCXiong Chen
Xiong Chen
XHXiaosi Hong
Xiaosi Hong
SLShulu Luo
Shulu Luo
JCJiahao Cai
Jiahao Cai
GHGuiwu Huang
Guiwu Huang
QCQinchang Chen
Qinchang Chen
Background: It has been observed that cancer and venous thromboembolism (VTE) are associated, but anticancer therapy may violate the causality. Therefore, this study aimed to elucidate the causal relationship of various cancers to VTE using Mendelian randomization (MR).Methods: Three MR methods were used to estimate causal effects: Inverse variance weighted (IVW), MR‐Egger and weighted median. Sensitivity analyses included Cochran's Q‐test, MR‐Egger intercept test and MR‐PRESSO. Gene ontology enrichment analysis was performed to elucidate the underlying mechanisms of VTE development in cancer patients.Results: The primary IVW approach showed that non‐Hodgkin's lymphoma (NHL) might increase the risk of VTE (odds ratio [OR]: 1.20, 95% confidence interval [95% CI]: 1.00–1.44, p = 0.045), while melanoma possibly reduced the risk of VTE (OR: 0.89, 95% CI: 0.82–0.97, p = 0.006), although there was no significance after adjustment for multiple testing. No association was observed between VTE risk and other site‐specific cancers. Gene ontology enrichment analysis revealed that vitamin D played an important role in the development of VTE in cancer patients.Conclusions: Our findings suggested that genetically predicted NHL was associated with higher VTE risk, whereas melanoma had lower VTE risk compared with other site‐specific cancers. Moreover, this study suggested that anticancer therapy and increased extensive examination might play a more important role in VTE development than the nature of cancer.